Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Pharmacology of Anti-Neoplastics: Preventing Extravasation and Its Consequences, Study notes of Pharmacology

The pharmacology of anti-neoplastics, focusing on the potential for extravasation and its damaging effects on tissues. Indications of extravasation, medications classified as vesicants, and ways to minimize extravasation are covered. Instructions for handling suspected extravasation are also provided.

What you will learn

  • Which medications are classified as vesicants?
  • What steps should be taken if extravasation is suspected?
  • What are the signs of extravasation with anti-neoplastics?

Typology: Study notes

2021/2022

Uploaded on 09/28/2022

smdixon22
smdixon22 🇺🇸

4

(1)

3 documents

1 / 1

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Pharmacology
Anti-Neoplastics
Extravasation with Anti-neoplastics
Vesicants are agents that, if deposited into the subcutaneous tissue (extravasation), cause
tissue necrosis and damage to underlying tendons, nerves, and blood vessels. The full
extent of tissue damage may take several weeks to become apparent.
Indications of extravasation include:
Absence of blood return from IV catheter
Resistance to flow of IV fluid
Swelling, pain, and/or redness to IV site
Some medications classified as vesicants:
Vinca Alkaloids and Antitumor Antibiotics
Daunorubicin, Doxorubicin (Adriamycin), Vincristine, Vinblastine, Nitrogen Mustard
If extravasation is suspected, stop drug administration immediately and administer
protocol according to institution’s policy. (Ex- aspiration of infiltrated drug and inject
neutralizing solution such as Hyaluronidase.)
Ways to minimize extravasation:
Check for blood return prior to drug administration
Good IV access or Implanted vascular access device
Slow administration of chemotherapeutic agent
Monitor IV access closely during administration
Have client report any s/s of swelling, pain, redness or burning to IV site
If you have to administer a combination of chemotherapeutic agents that consist of
vesicants and non-vesicants (such as irritants), you need to administer the non-vesicants
first. These are less likely to cause tissue destruction.

Partial preview of the text

Download Pharmacology of Anti-Neoplastics: Preventing Extravasation and Its Consequences and more Study notes Pharmacology in PDF only on Docsity!

Pharmacology

Anti-Neoplastics

Extravasation with Anti-neoplastics

Vesicants are agents that, if deposited into the subcutaneous tissue (extravasation), cause tissue necrosis and damage to underlying tendons, nerves, and blood vessels. The full extent of tissue damage may take several weeks to become apparent. Indications of extravasation include: Absence of blood return from IV catheter Resistance to flow of IV fluid Swelling, pain, and/or redness to IV site Some medications classified as vesicants: Vinca Alkaloids and Antitumor Antibiotics Daunorubicin, Doxorubicin (Adriamycin), Vincristine, Vinblastine, Nitrogen Mustard If extravasation is suspected, stop drug administration immediately and administer protocol according to institution’s policy. (Ex- aspiration of infiltrated drug and inject neutralizing solution such as Hyaluronidase.) Ways to minimize extravasation: Check for blood return prior to drug administration Good IV access or Implanted vascular access device Slow administration of chemotherapeutic agent Monitor IV access closely during administration Have client report any s/s of swelling, pain, redness or burning to IV site If you have to administer a combination of chemotherapeutic agents that consist of vesicants and non-vesicants (such as irritants), you need to administer the non-vesicants first. These are less likely to cause tissue destruction.